1. Home
  2. AWI vs BLTE Comparison

AWI vs BLTE Comparison

Compare AWI & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWI

Armstrong World Industries Inc

HOLD

Current Price

$177.22

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$160.86

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWI
BLTE
Founded
1860
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.6B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
AWI
BLTE
Price
$177.22
$160.86
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$208.83
$198.00
AVG Volume (30 Days)
326.2K
132.4K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
0.76%
N/A
EPS Growth
17.61
N/A
EPS
7.08
N/A
Revenue
$1,620,800,000.00
N/A
Revenue This Year
$10.32
N/A
Revenue Next Year
$6.71
$492.11
P/E Ratio
$25.22
N/A
Revenue Growth
12.11
N/A
52 Week Low
$137.45
$56.68
52 Week High
$206.08
$200.00

Technical Indicators

Market Signals
Indicator
AWI
BLTE
Relative Strength Index (RSI) 53.94 46.80
Support Level $161.33 $148.06
Resistance Level $198.38 $171.59
Average True Range (ATR) 4.27 7.08
MACD 0.63 -0.59
Stochastic Oscillator 52.27 20.62

Price Performance

Historical Comparison
AWI
BLTE

About AWI Armstrong World Industries Inc

Armstrong World Industries Inc designs and manufactures exterior architectural applications, including ceilings, specialty walls, and exterior metal solutions, using materials such as mineral fiber, fiberglass, metal, felt, architectural resin and glass, wood, wood fiber, and glass-reinforced-gypsum. Its segments include Mineral Fiber, which produces suspended mineral fiber and fiberglass ceiling systems and includes results from the Worthington Armstrong Venture (WAVE) for ceiling suspension system (grid) products; Architectural Specialties, which designs, produces, and sources specialty ceilings, walls, and other architectural applications for commercial settings, with revenues mainly project driven; and Unallocated Corporate. The company operates in the United States and Canada.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: